STOCK TITAN

Investor Notice: April 29th Deadline in Lawsuit for Investors who Lost over $50,000 in Cabaletta Bio, Inc. shares announced by Shareholders Foundation

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Negative)
Tags

SAN DIEGO, March 15, 2022 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a deadline is coming up on April 29th, 2022, in the lawsuit that was filed for certain investors in NASDAQ: CABA shares.

Investors who have losses of over $50,000 from their investment in shares of Cabaletta Bio, Inc. (NASDAQ: CABA) have certain options and there are short and strict deadlines running. Deadline: April 29, 2022. NASDAQ: CABA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On February 28, 2022, a lawsuit was filed against Cabaletta Bio, Inc. The plaintiff alleges that the Offering Documents in connection with the Company's initial public offering conducted on or about October 24, 2019 and that the Defendants between October 24, 2019 and December 13, 2021made false and/or misleading statements and/or failed to disclose that top-line data of the Phase 1 Clinical Trial indicated that DSG3-CAART had, among other things, worsened certain participants' disease activity scores and necessitated additional systemic medication to improve disease activity after DSG3-CAART infusion, that accordingly, DSG3-CAART was not as effective as the Company had represented to investors, that therefore, the Company had overstated DSG3-CAART's clinical and/or commercial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Cabaletta Bio, Inc. (NASDAQ: CABA) should contact the Shareholders Foundation, Inc.

CONTACT:
Shareholders Foundation, Inc. 
Michael Daniels 
+1 (858) 779-1554 
mail@shareholdersfoundation.com 
3111 Camino Del Rio North 
Suite 423 
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-notice-april-29th-deadline-in-lawsuit-for-investors-who-lost-over-50-000-in-cabaletta-bio-inc-shares-announced-by-shareholders-foundation-301502640.html

SOURCE Shareholders Foundation, Inc.

Cabaletta Bio, Inc.

NASDAQ:CABA

CABA Rankings

CABA Latest News

CABA Stock Data

117.31M
47.36M
3.1%
100.47%
7.59%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
PHILADELPHIA